Screener
Cytek Biosciences, Inc. CTKB Total Revenue
Total Revenue at other companies
Segments
Other financials
Where this comes from
Reported directly by Cytek Biosciences, Inc. in its filing.
Tagged under the XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax.
The source filing: Cytek Biosciences, Inc.’s 10-Q, filed August 5, 2026.
- Filed
- Aug 5, 2026, 5:06 PM EDT
- Fiscal quarter
- Q2 FY2026
- Calendar quarter
- Q2 2026
- Accession
- 0001628280-26-053496
| (In thousands, except share and per share data) | Three Months Ended June 30, 2026 | Three Months Ended June 30, 2025 | Six Months Ended June 30, 2026 | Six Months Ended June 30, 2025 |
|---|---|---|---|---|
| Revenue, net: | ||||
| Product | $32,556 | $31,415 | $61,335 | $59,525 |
| Service | 15,584 | 14,187 | 30,940 | 27,534 |
| Total revenue, net | 48,140 | 45,602 | 92,275 | 87,059 |
| Cost of sales: | ||||
| Product | 12,884 | 14,921 | 28,805 | 30,450 |
| Service | 6,916 | 6,814 | 13,876 | 12,585 |
| Total cost of sales | 19,800 | 21,735 | 42,681 | 43,035 |
Item 1. Consolidated Financial Statements (Unaudited)
FAQ
- What is Cytek Biosciences, Inc.'s total revenue?
- Cytek Biosciences, Inc. (CTKB) reported total revenue of $48.14M in Q2 2026.
- How has Cytek Biosciences, Inc.'s total revenue changed year-over-year?
- Cytek Biosciences, Inc.'s total revenue increased by 5.6% year-over-year, from $45.6M to $48.14M.
- What is the long-term trend for Cytek Biosciences, Inc.'s total revenue?
- Over 4 years (2021 to 2025), Cytek Biosciences, Inc.'s total revenue has grown at a 12.0% compound annual growth rate (CAGR), from $127.95M to $201.49M.
- What does total revenue mean?
- The aggregate of all revenue from the company's operations — the top line from which all profitability metrics are derived.
Ask your AI about Cytek Biosciences, Inc.'s total revenue.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude